Dr. Carlayne E. Jackson, MD

Dr. Jackson practices at UT Allied Health Therapeutics in San Antonio, Texas.

Dr. Jackson's NPI, 1083620967, was assigned on July 31, 2006. Dr. Jackson graduated from Joe R. & Teresa Lozano Long School of Medicine in 1987. Dr. Jackson holds Texas license H4435.

Dr. Jackson's primary practice is UT Allied Health Therapeutics, at 8403 Floyd Curl Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 567-8800.

Dr. Jackson's primary practice is UT Allied Health Therapeutics in San Antonio, Texas. Dr. Jackson is also affiliated with University Hospital. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Jackson to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jackson practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Jackson's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Jackson is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Jackson is licensed in Texas.

Dmand AI lists carpal tunnel syndrome, cerebrovascular disease, fibromyalgia and chronic pain, muscle disease and neuropathy among the conditions Dr. Jackson treats.

CMS data shows 210 Medicare services from Dr. Jackson across 5 procedure codes in 2024, for 95 Medicare patients. Medicare paid $14,803 for them. Every service was in an office.

CMS counts 95 Medicare patients who saw Dr. Jackson in 2024. The largest group is 65 to 74, with 35 patients. 71% of them have high blood pressure, and 67% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jackson's median patient age at 69, with 43% women.

In 2024, Dr. Jackson wrote 976 Medicare Part D claims for 163 patients. 55% of them were for generic drugs. CMS names the drug for 825 of them, across 22 drugs with 11 or more claims each, at $5,585,506 in total drug cost. In 2023, CMS named 1,468 claims across 28 drugs.

Dr. Jackson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jackson as offering telehealth.

Dmand AI links 109 papers to Dr. Jackson, published from 2006 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Amyotrophic Lateral Sclerosis, Double-Blind Method and Disease Progression. Dr. Jackson has published most often in Amyotroph Lateral Scler Frontotemporal Degener. Dr. Jackson's most frequent co-authors are James Bayard Caress, MD, Terry D. Heiman-Patterson, MD and Jonathan S. Katz, MD.

Dmand AI links Dr. Jackson to 7 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis, TDP-43 Proteinopathies and Myasthenia Gravis.

CMS Open Payments shows 308 general payments to Dr. Jackson from 16 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 36% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $94,933.

Dmand AI lists 3 awards for Dr. Jackson, most recently CMS Stage 1 EHR in 2013.

Dr. Jackson graduated from Joe R. & Teresa Lozano Long School of Medicine in 1987.

Dr. Jackson is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.